COVID-19 is an emerging, rapidly evolving situation.
Get the latest public health information from CDC:

Get the latest research information from NIH: Menu

Window of Opportunity Study of VS-6063 (Defactinib) in Surgical Resectable Malignant Pleural Mesothelioma Participants

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT02004028
Recruitment Status : Terminated (Company decided to discontinue trial to focus on development program next steps)
First Posted : December 6, 2013
Last Update Posted : October 22, 2019
Information provided by (Responsible Party):
Verastem, Inc.

No Study Results Posted on for this Study
Recruitment Status : Terminated
Actual Primary Completion Date : June 19, 2019
Actual Study Completion Date : June 19, 2019